Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice

Behavioural Brain Research

Volumn 268, Issue , 2014, Pages 117-126

  Smith, Craig M ^a,b   Chua, Berenice E ^a   Zhang, Cary ^a,b   Walker, Andrew W ^a,b   Haidar, Mouna ^a,b   Hawkes, David ^a   Shabanpoor, Fazel ^a,d   Hossain, Mohammad Akhter ^a,b   Wade, John D ^a,b   Rosengren, K Johan ^c   Gundlach, Andrew L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Arousal; Feeding; Motivation; Neuropeptide; Relaxin 3; RXFP3

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PLACEBO; RELAXIN 3; RELAXIN 3 RECEPTOR; RELAXIN 3 RECEPTOR ANTAGONIST PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; CENTRAL NERVOUS SYSTEM AGENTS; PEPTIDE; SALPR PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICIPATION; AROUSAL; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DIET RESTRICTION; DRUG SPECIFICITY; DRUG TARGETING; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; FEEDING BEHAVIOR; FOOD DEPRIVATION; FOOD INTAKE; FOOD SEEKING BEHAVIOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MALE; MOTIVATION; MOUSE; NEUROMODULATION; NONHUMAN; PALATABILITY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; APPETITE; C57BL MOUSE; DARKNESS; DIET; DRUG EFFECTS; EATING; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; ANTICIPATION, PSYCHOLOGICAL; APPETITIVE BEHAVIOR; CENTRAL NERVOUS SYSTEM AGENTS; DARKNESS; DIET; EATING; FOOD DEPRIVATION; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84899147561     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.037     Document Type: Article

References (88)

1. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005, 26:578-586.
2. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
3. Wright K.P., Lowry C.A., Lebourgeois M.K. Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 2012, 5:50.
4. Sara S.J., Bouret S. Orienting and reorienting: the locus coeruleus mediates cognition through arousal. Neuron 2012, 76:130-141.
5. Monti J.M. Serotonin control of sleep-wake behavior. Sleep Med Rev 2011, 15:269-281.
6. Kohlmeier K.A., Kristiansen U. GABAergic actions on cholinergic laterodorsal tegmental neurons: implications for control of behavioral state. Neuroscience 2010, 171:812-829.
7. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
8. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
9. Bathgate R.A.D., Samuel C.S., Burazin T.C.D., Layfield S., Claasz A.A., Reytomas I.G., Dawson N.F., Zhao C., Bond C., Summers R.J., et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 2002, 277:1148-1157.
10. Burazin T.C.D., Bathgate R.A.D., Macris M., Layfield S., Gundlach A.L., Tregear G.W. Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 2002, 82:1553-1557.
11. Tanaka M., Iijima N., Miyamoto Y., Fukusumi S., Itoh Y., Ozawa H., Ibata Y. Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 2005, 21:1659-1670.
12. Wilkinson T.N., Speed T.P., Tregear G.W., Bathgate R.A.D. Evolution of the relaxin-like peptide family. BMC Evol Biol 2005, 5:14.
13. Liu C., Eriste E., Sutton S., Chen J., Roland B., Kuei C., Farmer N., Jornvall H., Sillard R., Lovenberg T.W. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 2003, 278:50754-50764.
14. Bathgate R.A.D., Ivell R., Sanborn B.M., Sherwood O.D., Summers R.J. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006, 58:7-31.
15. Sutton S.W., Bonaventure P., Kuei C., Roland B., Chen J., Nepomuceno D., Lovenberg T.W., Liu C. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 2004, 80:298-307.
16. Ma S., Bonaventure P., Ferraro T., Shen P.J., Burazin T.C.D., Bathgate R.A.D., Liu C., Tregear G.W., Sutton S.W., Gundlach A.L. Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 2007, 144:165-190.
17. Ma S., Shen P.J., Sang Q., Lanciego J.L., Gundlach A.L. Distribution of relaxin-3 mRNA and immunoreactivity and RXFP3-binding sites in the brain of the macaque, Macaca fascicularis. Ann NY Acad Sci 2009, 1160:256-258.
18. Smith C.M., Shen P.J., Banerjee A., Bonaventure P., Ma S., Bathgate R.A.D., Sutton S.W., Gundlach A.L. Distribution of relaxin 3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 2010, 518:4016-4045.
19. Fiengo M., Del Gaudio R., Iazzetti G., Giaimo R.D., Minucci S., Aniello F., Donizetti A. Developmental expression pattern of two zebrafish rxfp3 paralogue genes. Dev, Growth Differ 2013, 55:766-775.
20. Bathgate R.A.D., Halls M.L., van der Westhuizen E.T., Callander G.E., Kocan M., Summers R.J. Relaxin family peptides and their receptors. Physiol Rev 2013, 93:405-480.
21. Ma S., Gundlach A.L. Relaxin-family peptide and receptor systems in brain: Insights from recent anatomical and functional studies. Adv Exp Med Biol 2007, 612:119-137.
22. Smith C.M., Ryan P.J., Hosken I.T., Ma S., Gundlach A.L. Relaxin-3 systems in the brain - the first 10 years. J Chem Neuroanat 2011, 42:262-275.
23. Ryan P.J., Ma S., Olucha-Bordonau F.E., Gundlach A.L. Nucleus incertus-an emerging modulatory role in arousal, stress and memory. Neurosci Biobehav Rev 2011, 35:1326-1341.
24. Goto M., Swanson L.W., Canteras N.S. Connections of the nucleus incertus. J Comp Neurol 2001, 438:86-122.
25. Olucha-Bordonau F.E., Teruel V., Barcia-Gonzalez J., Ruiz-Torner A., Valverde-Navarro A.A., Martinez-Soriano F. Cytoarchitecture and efferent projections of the nucleus incertus of the rat. J Comp Neurol 2003, 464:62-97.
26. Miyamoto Y., Watanabe Y., Tanaka M. Developmental expression and serotonergic regulation of relaxin 3/INSL7 in the nucleus incertus of rat brain. Regul Pept 2008, 145:54-59.
27. Greco M.A., Shiromani P.J. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Mol Brain Res 2001, 88:176-182.
28. Blasiak A., Gundlach A.L., Lewandowski M.H. Orexins increase nucleus incertus neuronal activity: implications for a possible reinforcing arousal drive. FENS Abstr 2010, 5:104.2.
29. Blasiak A., Blasiak T., Lewandowski M.H., Hossain M.A., Wade J.D., Gundlach A.L. Relaxin-3 innervation of the intergeniculate leaflet of the rat thalamus-neuronal tract-tracing and in vitro electrophysiological studies. Eur J Neurosci 2013, 37:1284-1294.
30. Morin L.P. Neuroanatomy of the extended circadian rhythm system. Exp Neurol 2013, 243:4-20.
31. Shinohara K., Tominaga K., Fukuhara C., Otori Y., Inouye S.I. Processing of photic information within the intergeniculate leaflet of the lateral geniculate body: assessed by neuropeptide Y immunoreactivity in the suprachiasmatic nucleus of rats. Neuroscience 1993, 56:813-822.
32. Saderi N., Cazarez-Marquez F., Buijs F.N., Salgado-Delgado R.C., Guzman-Ruiz M.A., del Carmen Basualdo M., Escobar C., Buijs R.M. The NPY intergeniculate leaflet projections to the suprachiasmatic nucleus transmit metabolic conditions. Neuroscience 2013, 246:291-300.
33. Cervera-Ferri A., Rahmani Y., Martinez-Bellver S., Teruel-Marti V., Martinez-Ricos J. Glutamatergic projection from the nucleus incertus to the septohippocampal system. Neurosci Lett 2012, 517:71-76.
34. McGowan B.M., Stanley S.A., Smith K.L., White N.E., Connolly M.M., Thompson E.L., Gardiner J.V., Murphy K.G., Ghatei M.A., Bloom S.R. Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 2005, 146:3295-3300.
35. Hida T., Takahashi E., Shikata K., Hirohashi T., Sawai T., Seiki T., Tanaka H., Kawai T., Ito O., Arai T., et al. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduction Res 2006, 26:147-158.
36. Liu C., Chen J., Kuei C., Sutton S., Nepomuceno D., Bonaventure P., Lovenberg T.W. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol Pharmacol 2005, 67:231-240.
37. Liu C., Chen J., Sutton S., Roland B., Kuei C., Farmer N., Sillard R., Lovenberg T.W. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J Biol Chem 2003, 278:50765-50770.
38. Bathgate R.A.D., Lin F., Hanson N.F., Otvos L., Guidolin A., Giannakis C., Bastiras S., Layfield S.L., Ferraro T., Ma S., et al. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 2006, 45:1043-1053.
39. McGowan B.M., Stanley S.A., White N.E., Spangeus A., Patterson M., Thompson E.L., Smith K.L., Donovan J., Gardiner J.V., Ghatei M.A., et al. Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab 2007, 292:E913-E919.
40. Otsubo H., Onaka T., Suzuki H., Katoh A., Ohbuchi T., Todoroki M., Kobayashi M., Fujihara H., Yokoyama T., Matsumoto T., et al. Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake. Peptides 2010, 31:1124-1130.
41. Shabanpoor F., Akhter Hossain M., Ryan P.J., Belgi A., Layfield S., Kocan M., Zhang S., Samuel C.S., Gundlach A.L., Bathgate R.A.D., et al. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. J Med Chem 2012, 55:1671-1681.
42. Kuei C., Sutton S., Bonaventure P., Pudiak C., Shelton J., Zhu J., Nepomuceno D., Wu J., Chen J., Kamme F. R3(B(23-27) R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7. J Biol Chem 2007, 282:25425-25435.
43. Haugaard-Kedström L.M., Shabanpoor F., Hossain M.A., Clark R.J., Ryan P.J., Craik D.J., Gundlach A.L., Wade J.D., Bathgate R.A.D., Rosengren K.J. Design, synthesis and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3. J Am Chem Soc 2011, 133:4965-4974.
44. Watanabe Y., Miyamoto Y., Matsuda T., Tanaka M. Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 2011, 43:169-174.
45. Ryan P.J., Buchler E., Shabanpoor F., Hossain M.A., Wade J.D., Lawrence A.J., Gundlach A.L. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat. Behav Brain Res 2013, 244:142-151.
46. Ma S., Olucha-Bordonau F.E., Hossain M.A., Lin F., Kuei C., Liu C., Wade J.D., Sutton S.W., Nunez A., Gundlach A.L. Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 2009, 16:730-742.
47. Ganella D.E., Ryan P.J., Bathgate R.A.D., Gundlach A.L. Increased feeding and body weight gain after acute/chronic hypothalamic activation of RXFP3 by relaxin-3 and receptor-selective synthetic and rAAV-driven agonist peptides: functional and therapeutic implications. Behav Pharmacol 2012, 23:516-525.
48. Smith C.M., Hosken I.T., Sutton S.W., Lawrence A.J., Gundlach A.L. Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 2012, 11:94-104.
49. Carneiro B.T., Araujo J.F. Food entrainment: major and recent findings. Front Behav Neurosci 2012, 6:83.
50. Verhagen L.A., Luijendijk M.C., de Groot J.W., van Dommelen L.P., Klimstra A.G., Adan R.A., Roeling T.A. Anticipation of meals during restricted feeding increases activity in the hypothalamus in rats. Eur J Neurosci 2011, 34:1485-1491.
51. Hsu C.T., Patton D.F., Mistlberger R.E., Steele A.D. Palatable meal anticipation in mice. PLoS One 2010, 5:e12903.
52. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, Sydney.
53. Crews E.C., Rowland N.E. Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes. Am J Physiol Regul Integr Comp Physiol 2005, 288:R638-R644.
54. Hossain M.A., Smith C.M., Ryan P.J., Buchler E., Bathgate R.A.D., Gundlach A.L., Wade J.D. Chemical synthesis and orexigenic activity of rat/mouse relaxin-3. Amino Acids 2013, 44:1529-1536.
55. Harri M., Lindblom J., Malinen H., Hyttinen M., Lapvetelainen T., Eskola S., Helminen H.J. Effect of access to a running wheel on behavior of C57BL/6J mice. Lab Anim Sci 1999, 49:401-405.
56. de Groot M.H., Rusak B. Housing conditions influence the expression of food-anticipatory activity in mice. Physiol Behav 2004, 83:447-457.
57. Gallardo C.M., Gunapala K.M., King O.D., Steele A.D. Daily scheduled high fat meals moderately entrain behavioral anticipatory activity, body temperature, and hypothalamic c-Fos activation. PLoS One 2012, 7:e41161.
58. Gunapala K.M., Gallardo C.M., Hsu C.T., Steele A.D. Single gene deletions of orexin, leptin, neuropeptide Y, and ghrelin do not appreciably alter food anticipatory activity in mice. PLoS One 2011, 6:e18377.
59. Ganella D.E., Callander G.E., Ma S., Bye C.R., Gundlach A.L., Bathgate R.A.D. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Ther 2013, 20:703-716.
60. Mistlberger R.E. Neurobiology of food anticipatory circadian rhythms. Physiol Behav 2011, 104:535-545.
61. Frederick-Duus D., Guyton M.F., Fadel J. Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 2007, 149:499-507.
62. Banerjee A., Shen P.-J., Gundlach A.L. Relaxin-3 neurons in nucleus incertus of the rat: effect on activity of psychological stress and the light-dark cycle. FENS Abstr 2006, 3:A117.2.
63. Lenglos C., Mitra A., Guevremont G., Timofeeva E. Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats. Genes Brain Behav 2013, 12:370-387.
64. Patton D.F., Mistlberger R.E. Circadian adaptations to meal timing: neuroendocrine mechanisms. Front Neurosci 2013, 7:185.
65. Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12:118-122.
66. Lawrence C.B., Snape A.C., Baudoin F.M., Luckman S.M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 2002, 143:155-162.
67. Ribeiro A.C., LeSauter J., Dupre C., Pfaff D.W. Relationship of arousal to circadian anticipatory behavior: ventromedial hypothalamus: one node in a hunger-arousal network. Eur J Neurosci 2009, 30:1730-1738.
68. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006, 494:528-548.
69. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
70. Merkestein M., Brans M.A., Luijendijk M.C., de Jong J.W., Egecioglu E., Dickson S.L., Adan R.A. Ghrelin mediates anticipation to a palatable meal in rats. Obesity (Silver Spring) 2012, 20:963-971.
71. Kay K., Parise E.M., Lilly N., Williams D.L. Hindbrain orexin 1 receptors influence palatable food intake, operant responding for food, and food-conditioned place preference in rats. Psychopharmacology (Berlin) 2013, 231:419-427.
72. 1-Adrenoceptors in the lateral septal area modulate food intake behaviour in rats. Br J Pharmacol 2008, 155:752-756.
73. Baker R.W., Osman J., Bodnar R.J. Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet. Pharmacol Biochem Behav 2001, 69:201-208.
74. Pratt W.E., Blackstone K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. Behav Brain Res 2009, 198:252-257.
75. Ishihara A., Tanaka T., Kanatani A., Fukami T., Ihara M., Fukuroda T. A potent neuropeptide Y antagonist, 1229U91, suppressed food intake in Zucker fatty rats. Am J Physiol Endocrinol Metab 1998, 274:R1500-R1504.
76. Olucha-Bordonau F.E., Otero-Garcia M., Sanchez-Perez A.M., Nunez A., Ma S., Gundlach A.L. Distribution and targets of the relaxin-3 innervation of the septal area in the rat. J Comp Neurol 2012, 520:1903-1939.
77. Ma S., Kastman H., Olucha-Bordonau F.E., Capogna M., Hossain A., Wade J.D., Verberne A.J.M., Gundlach A.L. Relaxin-3 receptor activation in the central amygdala enhances fear extinction in the rat: implications for relaxin-3 control of emotion. Soc Neurosci Abstr 2010, 40:P809.24.
78. McGowan B.M., Stanley S.A., Donovan J., Thompson E.L., Patterson M., Semjonous N.M., Gardiner J.V., Murphy K.G., Ghatei M.A., Bloom S.R. Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am J Physiol Endocrinol Metab 2008, 295:E278-E286.
79. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59:1151-1159.
80. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873.
81. Kudo T., Uchigashima M., Miyazaki T., Konno K., Yamasaki M., Yanagawa Y., Minami M., Watanabe M. Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci 2012, 32:18035-18046.
82. Ryan P.J., Kastman H.E., Krstrew E.V., Chirlov L., Rosengren K.J., Hossain M.A., Wade J.D., Gundlach A.L., Lawrence A.J. Relaxin-3/RXFP3 system regulates alcohol-seeking. Proc Nat Acad Sci USA 2013, 110:20789-20794.
83. Smith C.M., Hosken I.T., Downer N.L., Chua B.E., Hossain M.A., Wade J.D., Gundlach A.L. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice. Ital J Anat Embryol 2013, 118(Suppl 1):52-55.
84. Ganella D.E., Ma S., Gundlach A.L. Relaxin-3/RXFP3 signaling and neuroendocrine function-a perspective on extrinsic hypothalamic control. Front Endocrinol (Lausanne) 2013, 4:128.
85. Fox J.H., Lowry C.A. Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci 2013, 7:169.
86. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
87. Millan M.J., Agid Y., Brüne M., Bullmore E.T., Carter C.S., Clayton N.S., Connor R., Davis S., Deakin B., DeRubeis R.J., et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discovery 2012, 11:141-168.
88. Smith C.M., Walker A.W., Hosken I.T., Chua B.E., Zhang C., Haidar M., Gundlach A.L. Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?. Front Pharmacol 2014, 5:46.